Search Results 71-80 of 15172 for Inhibition
This image from our lab shows Nrf2 nuclear translocation in donor hearts after histone deacetylase inhibition. Purple and pink cultured cells depict ...
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma. Print details. Share ...
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With ...
PI3K-delta inhibitor TGR-1202 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Biological therapies, such as ...
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) ...
Angiogenesis inhibitors; Bacillus Calmette-Guerin therapy; Biochemotherapy; Cancer vaccines; Chimeric antigen receptor (CAR) T-cell therapy; Cytokine therapy ...
To exploit the dependence of tumors on glutamine, CB-839, a potent and selective inhibitor of the first enzyme in glutamine utilization, glutaminase, will be ...
... Inhibitor Associated Musculoskeletal Symptoms (AIMSS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...
Myostatin inhibition, even partial reductions, increases muscle mass in adult and older mammals. Myostatin's effects are highly specific to muscle mass ...
... inhibitor (ICI). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.